The medical device producer joined Trice Medical's existing investors in a $19.3m series C round that took the orthopaedic diagnostics technology provider's overall funding above $40m.
US-based orthopaedic diagnostics equipment developer Trice Medical completed a $19.3m series C round yesterday that included a strategic investment by medical device maker Smith & Nephew.
Existing backers including Safeguard Scientifics, HealthQuest Capital and BioStar Ventures also participated in the round, which increased Trice’s total funding to $40.9m, the company said.
Trice secured 510(K) clearance for its Mi-eye2 device, which uses a disposable needle equipped with a wide-angle camera lens to help physicians remotely diagnose injuries in a patient’s joints,…
